EHRA Premium Access

The metabolic modulator trimetazidine inhibits AF-induced atrial structural remodelling

Topic: Atrial Fibrillation - Pathophysiology and Mechanisms

Congress Session

About the speaker

Mr Dragan Opacic

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
0 follower

5 more presentations in this session

Plasminogen activator inhibitor-1 as a predictor of recurrence atrial fibrillation after radiofrequency catheter ablation of pulmonary veins

Speaker: Doctor R. Rekvava (Almaty, KZ)

Thumbnail

Circulating miRNAs expression in atrial fibrillation patients candidates to transcatheter ablation

Speaker: Doctor A. Galli (Brussels, BE)

Thumbnail

In-vivo and cellular left atrial function in an experimental model of heart failure with preserved ejection fraction

Speaker: Doctor F. Hohendanner (Berlin, DE)

Thumbnail

digoxin and platelet activation in atrial fibrillation patients.

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Thumbnail

Ivabradine-induced atrial tachyarrhythmias in healthy rats

Speaker: Mr B. Finascu (Tirgu Mures, RO)

Thumbnail

Access the full session

Poster session 1 - Basic Science

Speakers: Mr D. Opacic, Doctor R. Rekvava, Doctor A. Galli, Doctor F. Hohendanner, Professor P. Pignatelli Spinazzola...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk